These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29500794)

  • 21. The pharmacodynamics of torsemide in patients with congestive heart failure.
    Vargo D; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):48-54. PubMed ID: 8033494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.
    Liu C; Liu G; Zhou C; Ji Z; Zhen Y; Liu K
    Can J Cardiol; 2007 Sep; 23(11):865-8. PubMed ID: 17876376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.
    Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.
    van Kraaij DJ; Jansen RW; Gribnau FW; Hoefnagels WH
    Drugs Aging; 2000 Apr; 16(4):289-300. PubMed ID: 10874524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs.
    Wehling M
    J Am Med Dir Assoc; 2013 Jun; 14(6):437-42. PubMed ID: 23510827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to optimize the use of diuretics in patients with heart failure?
    Burnier M; Narkiewicz K; Kjeldsen SE
    Kardiol Pol; 2023; 81(10):944-949. PubMed ID: 37718589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuretics in cardiovascular therapy. Perusing the past, practising in the present, preparing for the future.
    Taylor SH
    Z Kardiol; 1985; 74 Suppl 2():2-12. PubMed ID: 3890392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 2018 overview of diuretic resistance in heart failure.
    Jardim SI; Ramos Dos Santos L; Araújo I; Marques F; Branco P; Gaspar A; Fonseca C
    Rev Port Cardiol (Engl Ed); 2018 Nov; 37(11):935-945. PubMed ID: 30470451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of diuretics in congestive heart failure.
    Brater DC
    Semin Nephrol; 1994 Sep; 14(5):479-84. PubMed ID: 7997652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of diuretics.
    Brater DC
    Am J Med Sci; 2000 Jan; 319(1):38-50. PubMed ID: 10653443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic treatment for the sodium retention of congestive heart failure.
    Cody RJ; Kubo SH; Pickworth KK
    Arch Intern Med; 1994 Sep; 154(17):1905-14. PubMed ID: 8074594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical pharmacology of loop diuretics in the pediatric patient.
    Eades SK; Christensen ML
    Pediatr Nephrol; 1998 Sep; 12(7):603-16. PubMed ID: 9761364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.
    Costanzo MR; Saltzberg MT; Jessup M; Teerlink JR; Sobotka PA;
    J Card Fail; 2010 Apr; 16(4):277-84. PubMed ID: 20350693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application.
    Palazzuoli A; Ruocco G; Pellegrini M; Beltrami M; Del Castillo G; Nuti R
    Curr Drug Targets; 2015; 16(11):1246-53. PubMed ID: 25892312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diuretic therapy in patients with congestive heart failure: an update].
    Aspromonte N; Ria P; Bonello M
    G Ital Nefrol; 2012; 29(1):33-43. PubMed ID: 22388904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretic resistance in patients with kidney disease: Challenges and opportunities.
    Guo L; Fu B; Liu Y; Hao N; Ji Y; Yang H
    Biomed Pharmacother; 2023 Jan; 157():114058. PubMed ID: 36473405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
    Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.